Skip to main content

Table 1 Randomized controlled trials evaluating the effect of systematic screening of coronary artery disease in the risk of major cardiovascular adverse events in people with diabetes

From: Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design

Study

Population

Inclusion period

Follow-up (years)

Primary outcome

Sample size

Number of events

Expected incidence (%/year)

Observed incidence (%/year)

Hazard ratio (95% CI)

Faglia et al. [16]

T2DM

Age 46–75 years

+\(\ge \) 2 CV risk factors

1998–1999

4.5

Major (cardiac death or MI) or minor (resting and effort angina) event

141

19

3

3

-

DIAD [11]

T2DM

Age 50–70 years

2000–2002

4.8

Non-fatal MI or CV death

1123

32

1—2

0.6

0.88 (0.44–1.88)

DYNAMIT [12]

DT2M

Age 55–75 years

+\(\ge \) 2 CV risk factors

2000–2003

3.5

All-cause death, non-fatal MI, non-fatal stroke, HH requiring hospitalization or visit to emergency department

631

54

5.5

2.4

1.00 (0.59–1.71)

FACTOR-64 [13]

T2DM + T1DM

Men \(\ge \) 50, Women \(\ge \) 55 years

diabetes duration \(\ge \) 3 years

or

Men \(\ge \) 40 years, Women \(\ge \) 45y + Diabetes duration \(\ge \) 5 years

2007–2013

4.0

All-cause death, nonfatal MI, or hospitalization for unstable angina

900

62

8

1.7

0.80 (0.49–1.32)

DADDY-D [14]

T2DM

Age 50–70 years

10-year CV risk score ≥ 10%

2007–2012

3.6

Non-fatal MI or CV death

520

26

2.6

1.4

0.85 (0.39–1.83)

  1. T2DM type 2 diabetes mellitus, T1DM type 1 diabetes mellitus, CV cardiovascular, MI myocardial infarction, HH heart failure